V. Hofman

N. Le Stang, N. Girard, A. Nicholson, 2018, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications

J. Zucman‐Rossi, M. Copin, M. Jaurand, 2019, Nature Communications.

Cytopathologic detection of circulating tumor cells using the isolation by size of epithelial tumor cell method: promises and pitfalls.

T. Molina, S. Lantuejoul, P. Bahadoran, 2011, American journal of clinical pathology.

Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): protocol of a prospective multicentre cohort study in France

C. Marquette, S. Leroy, J. Mazières, 2017, BMJ Open.

Prognostic significance of cortactin levels in head and neck squamous cell carcinoma: comparison with epidermal growth factor receptor status

N. Guevara, J. Santini, E. Van Obberghen-Schilling, 2008, British Journal of Cancer.

Setting up a Prospective Thyroid Biobank for Translational Research: Practical Approach of a Single Institution (2004-2009, Pasteur Hospital, Nice, France).

N. Guevara, L. Castillo, J. Santini, 2011, Biopreservation and biobanking.

The value of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection

L. Castillo, J. Santini, E. Selva, 2004, Pathology.

Afa/Dr Diffusely Adhering Escherichia coli Infection in T84 Cell Monolayers Induces Increased Neutrophil Transepithelial Migration, Which in Turn Promotes Cytokine-Dependent Upregulation of Decay-Accelerating Factor (CD55), the Receptor for Afa/Dr Adhesins

P. Brest, P. Hofman, A. Servin, 2003, Infection and Immunity.

The Afa/Dr Adhesins of Diffusely Adhering Escherichia coli Stimulate Interleukin-8 Secretion, Activate Mitogen-Activated Protein Kinases, and Promote Polymorphonuclear Transepithelial Migration in T84 Polarized Epithelial Cells

P. Brest, P. Hofman, A. Servin, 2003, Infection and Immunity.

[Value of PCR amplification from formalin-fixed paraffin-embedded tissues in the diagnosis of Mycobacterium tuberculosis infection].

L. Landraud, L. Castillo, E. Selva, 2003, Annales de pathologie.

Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival

S. Imbeaud, J. Zucman‐Rossi, M. Copin, 2020, Molecular oncology.

Resistances to EGFR tyrosine kinase inhibitors in lung cancer-how to routinely track them in a molecular pathology laboratory?

P. Hofman, V. Hofman, 2019, Journal of thoracic disease.

Diagnostic value of immunohistochemistry for the detection of the BRAFV600E mutation in primary lung adenocarcinoma Caucasian patients.

A. von Deimling, C. Marquette, D. Capper, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

PELVIC EPENDYMOMA ARISING FROM THE SMALL BOWEL

V. Hofman, J. Michiels, J. Hassoun, 2001, Pathology.

[The French mesothelioma network from 1998 to 2013].

N. Le Stang, F. Galateau-Sallé, P. Hainaut, 2014, Annales de pathologie.

Immunohistochemistry as a potential tool for routine detection of the NRAS Q61R mutation in patients with metastatic melanoma.

P. Bahadoran, R. Ballotti, G. Poissonnet, 2015, Journal of the American Academy of Dermatology.

Comparison of Two Rapid Assays for the Detection of BRAF V600 Mutations in Metastatic Melanoma including Positive Sentinel Lymph Nodes

G. Poissonnet, P. Hofman, C. Bonnetaud, 2022, Diagnostics.

Usefulness of immunocytochemistry for the detection of the BRAF(V600E) mutation in circulating tumor cells from metastatic melanoma patients.

P. Bahadoran, G. Poissonnet, J. Emile, 2013, The Journal of investigative dermatology.

Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of cytogenetic and molecular genetic analyses.

A. Aurias, A. Italiano, P. Hofman, 2007, Cancer genetics and cytogenetics.

Monitoring BRAF and NRAS mutations with cell-free circulating tumor DNA from metastatic melanoma patients

R. Schiappa, P. Hofman, C. Bonnetaud, 2018, Oncotarget.

Sarcoid-like lesions associated with the immune restoration inflammatory syndrome in AIDS: absence of polymerase chain reaction detection of Mycobacterium tuberculosis in granulomas isolated by laser capture microdissection

E. Selva, P. Hofman, V. Hofman, 2006, Virchows Archiv.

Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test

C. Marquette, S. Leroy, P. Brest, 2021, Microbiology spectrum.

Establishment of a Collection of Blood-Derived Products from COVID-19 Patients for Translational Research: Experience of the LPCE Biobank (Nice, France).

C. Marquette, S. Leroy, E. Selva, 2020, Biopreservation and biobanking.

V. Hofman, M. Ilié, H. Quintens, 2019, Therapeutic advances in urology.

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution

C. Marquette, J. Benzaquen, P. Hofman, 2020, Journal of Translational Medicine.

Lung pathology in COVID-19

M. Copin, V. Hofman, J. Gibier, 2021, COVID-19.

MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib

N. Guevara, A. Bozec, J. Santini, 2016, Oncotarget.

Glut-1 intensity and pattern of expression in thymic epithelial tumors are predictive of WHO subtypes.

N. Girard, T. Molina, A. Marx, 2015, Pathology, research and practice.

Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility

N. Guevara, J. Santini, B. Franc, 2009, Virchows Archiv.

Diagnostic value of immunohistochemistry for the detection of the BRAF(V600E) mutation in papillary thyroid carcinoma: comparative analysis with three DNA-based assays.

A. von Deimling, D. Capper, N. Guevara, 2014, Thyroid : official journal of the American Thyroid Association.

Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?

N. Guevara, J. Santini, P. Barbry, 2011, Endocrine-related cancer.

Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients

C. Marquette, S. Leroy, J. Benzaquen, 2018, Cancers.

Morphologic and molecular classification of lung neuroendocrine neoplasms

G. Pelosi, M. Papotti, G. Veronesi, 2021, Virchows Archiv.

Any Place for Immunohistochemistry within the Predictive Biomarkers of Treatment in Lung Cancer Patients?

P. Hofman, V. Hofman, E. Long-Mira, 2018, Cancers.

Prospective multi-center validation of the detection of ALK rearrangements of circulating tumor cells for non-invasive longitudinal management of patients with advanced non-small cell lung cancer.

C. Marquette, J. Thariat, J. Mazières, 2021, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

P2RX7B is a new theranostic marker for lung adenocarcinoma patients

S. Saccani, C. Marquette, S. Leroy, 2020, Theranostics.

The histological spectrum of visceral leishmaniasis caused by Leishmania infantum MON-1 in acquired immune deficiency syndrome.

F. Pratlong, N. Glaichenhaus, V. Hofman, 2000, Human pathology.

Setting Up an Ultra-Fast Next-Generation Sequencing Approach as Reflex Testing at Diagnosis of Non-Squamous Non-Small Cell Lung Cancer; Experience of a Single Center (LPCE, Nice, France)

C. Marquette, J. Benzaquen, P. Hofman, 2022, Cancers.

Usefulness of molecular biology performed with formaldehyde-fixed paraffin embedded tissue for the diagnosis of combined pulmonary invasive mucormycosis and aspergillosis in an immunocompromised patient

P. Hofman, M. Gari-Toussaint, M. Baumann, 2010, Diagnostic pathology.

Setting-Up a Rapid SARS-CoV-2 Genome Assessment by Next-Generation Sequencing in an Academic Hospital Center (LPCE, Louis Pasteur Hospital, Nice, France)

C. Marquette, S. Leroy, R. Schiappa, 2022, Frontiers in Medicine.

Ensuring the Safety and Security of Frozen Lung Cancer Tissue Collections through the Encapsulation of Dried DNA

Georges Dagher, C. Marquette, E. Gormally, 2018, Cancers.

Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How?

Georges Dagher, C. Marquette, E. Gormally, 2018, Cancers.

Epithelial-to-mesenchymal transition promotes immune escape by inducing CD70 in non-small cell lung cancer.

S. Boyault, S. Lantuejoul, C. Caux, 2022, European journal of cancer.

A case report of exogenous lipoid pneumonia associated with avocado/soybean unsaponifiables

C. Marquette, S. Leroy, Y. Diascorn, 2019, BMC pulmonary medicine.

Detection and characterization of circulating tumor cells in lung cancer: Why and how?

P. Hofman, V. Hofman, M. Ilié, 2016, Cancer cytopathology.

Use of circulating tumor cells in prospective clinical trials for NSCLC patients – standardization of the pre-analytical conditions

C. Marquette, S. Leroy, P. Hofman, 2018, Clinical chemistry and laboratory medicine.

Critical Assessment in Routine Clinical Practice of Liquid Biopsy for EGFR Status Testing in Non-Small-Cell Lung Cancer: A Single-Laboratory Experience (LPCE, Nice, France).

C. Marquette, S. Leroy, M. Denis, 2019, Clinical lung cancer.

Circulating Tumor Cell Detection in Lung Cancer: But to What End?

C. Marquette, P. Hofman, V. Hofman, 2019, Cancers.

Epithelial Intestinal Cell Apoptosis Induced byHelicobacter pylori Depends on Expression of thecag Pathogenicity Island Phenotype

B. Rossi, P. Hofman, B. Mograbi, 2001, Infection and Immunity.

Human Polymorphonuclear Leukocytes are Sensitive In Vitro to Helicobacter pylori VacA Toxin

P. Auberger, E. Selva, P. Brest, 2006, Helicobacter.

Effect of Helicobacter pylori on Polymorphonuclear Leukocyte Migration across Polarized T84 Epithelial Cell Monolayers: Role of Vacuolating Toxin VacA and cagPathogenicity Island

P. Auberger, A. Galmiche, P. Boquet, 2000, Infection and Immunity.

Effect of Helicobacter pylori on Polymorphonuclear Leukocyte Migration across Polarized T84 Epithelial Cell Monolayers: Role of Vacuolating Toxin VacA and cag Pathogenicity Island

P. Auberger, A. Galmiche, P. Boquet, 2000 .

Pathogenesis of Helicobacter pylori Infection

S. Bereswill, P. Brest, P. Hofman, 2004, Helicobacter.

Helicobacter pylori Lipopolysaccharide Hinders Polymorphonuclear Leucocyte Apoptosis

P. Auberger, F. Luciano, P. Boquet, 2001, Laboratory Investigation.

Oncocytic lipoadenoma of the parotid gland: Immunohistochemical and cytogenetic analysis.

J. Santini, P. Hofman, V. Hofman, 2010, Pathology, research and practice.

Detection of ALK fusion transcripts in plasma of non-small cell lung cancer patients using a novel RT-PCR based assay

C. Marquette, J. Thariat, J. Mazières, 2020, Annals of translational medicine.

Real-world assessment of the BRAF status in non-squamous cell lung carcinoma using VE1 immunohistochemistry: A single laboratory experience (LPCE, Nice, France).

C. Marquette, F. Barlesi, J. Benzaquen, 2020, Lung cancer.

Immune biomarkers in thymic epithelial tumors: expression patterns, prognostic value and comparison of diagnostic tests for PD-L1

N. Girard, F. Galateau-Sallé, T. Molina, 2019, Biomarker Research.

Use of the 22C3 anti–programmed death‐ligand 1 antibody to determine programmed death‐ligand 1 expression in cytology samples obtained from non–small cell lung cancer patients

J. Juco, S. Khambata-Ford, P. Hofman, 2018, Cancer cytopathology.

E2F1 inhibition mediates cell death of metastatic melanoma

P. Abbe, C. Bertolotto, R. Ballotti, 2018, Cell Death & Disease.

Fatal Staphylococcus aureus haemorrhagic pneumonia producing Panton-Valentine leucocidin

P. Hofman, V. Hofman, C. Pulcini, 2007, Scandinavian journal of infectious diseases.

Brief Report: Comparison of three sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer demonstrates low comparability.

C. Marquette, J. Benzaquen, P. Hofman, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Brief Report: Correlation cannot be used to compare sequencing panels used for the assessment of tumor mutational burden in non-small cell lung cancer.

C. Marquette, J. Benzaquen, P. Hofman, 2020, medRxiv.

Escherichia coli cytotoxic necrotizing factor‐1 (CNF‐1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis

G. Le Negrate, P. Boquet, P. Brest, 2000, Journal of leukocyte biology.

The Rho GTPase activators CNF1 and DNT bacterial toxins have mucosal adjuvant properties.

C. Czerkinsky, E. Lemichez, V. Hofman, 2005, Vaccine.

Rho GTPase Is Activated by Cytotoxic Necrotizing Factor 1 in Peripheral Blood T Lymphocytes: Potential Cytotoxicity for Intestinal Epithelial Cells

P. Auberger, A. Loubat, P. Brest, 2003, Infection and Immunity.

Intestinal occlusion caused by Rosai-Dorfman disease mimicking colonic diverticulitis.

P. Hofman, V. Hofman, S. Lassalle, 2007, Pathology, research and practice.

Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches

C. Marquette, J. Benzaquen, P. Hofman, 2022, Journal of personalized medicine.

Molecular Profiling in Non-Squamous Non-Small Cell Lung Carcinoma: Towards a Switch to Next-Generation Sequencing Reflex Testing

C. Marquette, J. Benzaquen, P. Hofman, 2022, Journal of personalized medicine.

Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer

C. Marquette, S. Leroy, J. Sabourin, 2017, Oncotarget.

Identification of a circulating immunological signature predictive of response to immune checkpoint inhibitors in patients with advanced non‐small cell lung cancer

C. Marquette, P. Brest, J. Benzaquen, 2022, Clinical and translational medicine.

Micronodular thymic carcinoma with lymphoid hyperplasia: relevance of immunohistochemistry with a small panel of antibodies for diagnosis—a RYTHMIC study

N. Girard, T. Molina, A. Marx, 2021, Virchows Archiv.

Impact of expert pathologic review of thymic epithelial tumours on diagnosis and management in a real-life setting: A RYTHMIC study.

N. Girard, T. Molina, A. Marx, 2020, European journal of cancer.

[The Nice CHU biobank experience to collect patients' informed consent for research context (2004-2009)].

N. Guevara, L. Castillo, J. Santini, 2010, Annales de pathologie.

Disseminated infection caused by Sparganum proliferum in an AIDS patient

N. Rioux-Leclercq, P. Hofman, V. Hofman, 2010, Histopathology.

Immunostaining of visceral leishmaniasis caused by Leishmania infantum using monoclonal antibody (19-11) to the Leishmania homologue of receptors for activated C-kinase.

P. Brousset, N. Glaichenhaus, P. Hofman, 2003, American journal of clinical pathology.

Primary clear cell meningioma of the orbit mimicking a metastatic carcinoma: usefulness of immunohistochemistry and cytogenetic analysis

G. Odin, P. Hofman, V. Hofman, 2008, Virchows Archiv.

Diagnosis of primary esophageal synovial sarcoma by demonstration of t(X;18) translocation: a case report

P. Hofman, V. Hofman, J. Mouroux, 2006, Virchows Archiv.

High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness

E. Gilson, P. Bahadoran, R. Ballotti, 2016, Cancer medicine.

Why and how immunohistochemistry should now be used to screen for the BRAFV600E status in metastatic melanoma? The experience of a single institution (LCEP, Nice, France)

P. Laurent-Puig, P. Bahadoran, G. Poissonnet, 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

Impact of Kras mutant subtypes on PD-L1 expression in lung adenocarcinoma

C. Marquette, P. Brest, P. Hofman, 2016 .

Measuring the contribution of tumor biobanks to research in oncology: surrogate indicators and bibliographic output.

A. Cambon-Thomsen, Georges Dagher, B. Parodi, 2013, Biopreservation and biobanking.

Usefulness of oral cytopathology in the diagnosis of infectious diseases

P. Vielh, P. Hofman, P. Braz-Silva, 2010, Cytopathology : official journal of the British Society for Clinical Cytology.

Usefulness of frozen section in rhinocerebral mucormycosis diagnosis and management

N. Guevara, L. Castillo, P. Hofman, 2003, Pathology.

Pneumopathie Cunninghamella bertholletiae compliquant une leucmie aige lymphoblastique

P. Hofman, M. Gari-Toussaint, V. Hofman, 2007 .

Longterm survival in acute rhinocerebral mucormycosis with giant cell arteritis and foreign body granulomas.

J. Santini, V. Hofman, P. Hofman, 2001, Pathology, research and practice.

[Pneumonia caused by Cunninghamella bertholletiae in a patient with acute lymphoblastic leukemia].

P. Hofman, M. Gari-Toussaint, V. Hofman, 2007, Annales de pathologie.

An expansive paranasal sinus tumour‐like lesion caused by Bipolaris spicifera in an immunocompetent patient

M. Gari-Toussaint, V. Hofman, D. Ambrosetti, 2006, Histopathology.

[Disseminated pulmonary infection due to Cryptococcus neoformans in a non immunocompromised patient].

P. Hofman, V. Hofman, J. Mouroux, 2004, Annales de pathologie.

Aureobasidium pullulans contamination in bronchial aspirates mimicking cryptococcosis: a rare diagnostic pitfall.

P. Hofman, V. Hofman, É. Long, 2008, Pathology.

A pseudo tumoral sinusitis caused by Bipolaris sp.

S. Chanalet, M. Gari-Toussaint, V. Hofman, 2006, The Journal of infection.

Senescent cells develop a PARP-1 and nuclear factor-{kappa}B-associated secretome (PNAS).

K. Bille, C. Bertolotto, R. Ballotti, 2011, Genes & Development.

Microphthalmia-associated transcription factor controls the DNA damage response and a lineage-specific senescence program in melanomas.

Laurent Beuret, K. Bille, P. Bahadoran, 2010, Cancer research.

Daily Practice Assessment of KRAS Status in NSCLC Patients: A New Challenge for the Thoracic Pathologist Is Right around the Corner

P. Brest, P. Hofman, B. Mograbi, 2022, Cancers.

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Aurélie A G Gabriel, N. Le Stang, N. Girard, 2019, Nature Communications.

Amplification loop of the inflammatory process is induced by P2X7R activation in intestinal epithelial cells in response to neutrophil transepithelial migration.

X. Hébuterne, R. Unwin, P. Brest, 2010, American journal of physiology. Gastrointestinal and liver physiology.

Usefulness of ancillary methods for diagnosis, prognosis and targeted therapy in thyroid pathology.

A. Bozec, J. Santini, P. Hofman, 2013, Current medicinal chemistry.

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.

P. Abbe, C. Bertolotto, R. Ballotti, 2016, Cancer cell.

In-House Implementation of Tumor Mutational Burden Testing to Predict Durable Clinical Benefit in Non-Small Cell Lung Cancer and Melanoma Patients

A. Stenzinger, C. Marquette, J. Benzaquen, 2019, Cancers.

Assessment of the PD-L1 status by immunohistochemistry: challenges and perspectives for therapeutic strategies in lung cancer patients

Marius Ilie, Manfred Dietel, Paul Hofman, 2016, Virchows Archiv.

Single-cell RNA-seq characterization of lung fibrosis resolution reveals a delayed capillary endothelial signature associated with alveolar regeneration in aged mice

S. Bellusci, P. Barbry, N. Pottier, 2023, Revue des Maladies Respiratoires.

Disentangling heterogeneity of Malignant Pleural Mesothelioma through deep integrative omics analyses

Erik N. Bergstrom, P. Courtiol, C. Maussion, 2021, bioRxiv.

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells

P. Bahadoran, C. Bertolotto, R. Ballotti, 2012, Oncogene.

Mitf is the key molecular switch between mouse or human melanoma initiating cells and their differentiated progeny

P. Bahadoran, C. Bertolotto, R. Ballotti, 2011, Oncogene.

Single-cell genetic analysis validates cytopathological identification of circulating cancer cells in patients with clear cell renal cell carcinoma

C. Béroud, P. Hofman, V. Hofman, 2018, Oncotarget.

Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer

C. Marquette, S. Leroy, E. Selva, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.

Treatment strategies for thymic carcinoma in a real-life setting. Insights from the RYTHMIC network.

N. Girard, T. Molina, L. Thiberville, 2021, European journal of cancer.

Setting up a wide panel of patient-derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps

P. Vrignaud, A. Merino-Trigo, E. Selva, 2014, Cancer medicine.

Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 therapeutic strategies.

C. Marquette, J. Sabourin, P. Hofman, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma.

S. Lantuejoul, J. Adam, D. Damotte, 2019, Journal of thoracic disease.

The liquid biopsy: a tool for a combined diagnostic and theranostic approach for care of a patient with late-stage lung carcinoma presenting with bilateral ocular metastases

C. Marquette, J. Thariat, P. Hofman, 2017, Expert review of anticancer therapy.

P2.09-17 Real-World Concordance Across Pathologists for PD-L1 Scoring in Non-Small Cell Lung Cancer: Results from a Large Nationwide Initiative

M. Copin, S. Lantuejoul, F. Penault-Llorca, 2019, Journal of Thoracic Oncology.

Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma

P. Hofman, C. Bonnetaud, V. Hofman, 2010, Virchows Archiv.

NF-kB2 induces senescence bypass in melanoma via a direct transcriptional activation of EZH2

P. Bahadoran, C. Bertolotto, R. Ballotti, 2016, Oncogene.

MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells.

J. Santini, P. Barbry, B. Mari, 2011, Endocrine-related cancer.

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

C. Marquette, P. Hofman, V. Hofman, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Comprehensive molecular and pathological evaluation of transitional mesothelioma assisted by deep learning approach: a multi institutional study of the International Mesothelioma Panel from MESOPATH Reference Center.

G. Wainrib, P. Courtiol, C. Maussion, 2020, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[Liposarcoma of the pleura: an exceptional tumor. A study of two cases].

P. Hofman, V. Hofman, J. Mouroux, 2003, Annales de pathologie.

Correction: Use of the 22C3 anti-PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms

C. Copie-Bergman, J. Juco, S. Khambata-Ford, 2017, PloS one.

Use of the 22C3 anti–PD-L1 antibody to determine PD-L1 expression in multiple automated immunohistochemistry platforms

C. Copie-Bergman, J. Juco, S. Khambata-Ford, 2017, PloS one.

Deciphering the Role of Oncogenic MITFE318K in Senescence Delay and Melanoma Progression

K. Bille, C. Bertolotto, F. Luciani, 2017, Journal of the National Cancer Institute.

Preoperative Circulating Tumor Cell Detection Using the Isolation by Size of Epithelial Tumor Cell Method for Patients with Lung Cancer Is a New Prognostic Biomarker

T. Molina, J. Jais, S. Lantuejoul, 2010, Clinical Cancer Research.

cell death in thyroid cancer cells

S. Antipolis, J. Santini, P. Barbry, 2011 .

Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors.

S. Leroy, P. Hofman, V. Hofman, 2019, Journal of thoracic disease.

Deep Learning Facilitates Distinguishing Histologic Subtypes of Pulmonary Neuroendocrine Tumors on Digital Whole-Slide Images

N. Ayache, C. Marquette, J. Benzaquen, 2022, Cancers.

Predictive clinical outcome of the intratumoral CD66b‐positive neutrophil‐to‐CD8‐positive T‐cell ratio in patients with resectable nonsmall cell lung cancer

P. Hofman, C. Bonnetaud, V. Hofman, 2012, Cancer.

Clinical and molecular practice of European thoracic pathology laboratories during the COVID-19 pandemic. The past and the near future

A. Hofman, S. Cajal, P. Brousset, 2020, ESMO Open.

Assessment of morphology, antigenicity, and nucleic acid integrity for diagnostic thyroid pathology using formalin substitute fixatives.

J. Santini, E. Selva, P. Brest, 2009, Thyroid : official journal of the American Thyroid Association.

EGFR and KRAS status of primary sarcomatoid carcinomas of the lung: Implications for anti‐EGFR treatment of a rare lung malignancy

A. Italiano, P. Hofman, V. Hofman, 2009, International journal of cancer.

Prospective evaluation of NGS-based liquid biopsy in untreated late stage non-squamous lung carcinoma in a single institution

C. Marquette, J. Benzaquen, P. Hofman, 2020, Journal of Translational Medicine.

Fusion‐positive non‐small cell lung carcinoma: Biological principles, clinical practice, and diagnostic implications

D. Kazdal, P. Hofman, V. Hofman, 2022, Genes, chromosomes & cancer.

BRAFV600E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer

J. Merlio, J. Emile, H. Bégueret, 2014, Pathology.

E mutation analysis by immunohistochemistry in patients with thoracic metastases from colorectal cancer

H. Bégueret, X. Hébuterne, P. Hofman, 2014 .

In papillary thyroid carcinoma, TIMP-1 expression correlates with BRAFV600E mutation status and together with hypoxia-related proteins predicts aggressive behavior

N. Guevara, A. Bozec, J. Santini, 2013, Virchows Archiv.

KRAS Mutations in Lung Adenocarcinoma: Molecular and Epidemiological Characteristics, Methods for Detection, and Therapeutic Strategy Perspectives.

A. Didier, C. Marquette, J. Mazières, 2015, Current molecular medicine.

[Role of the surgical pathology laboratory in the pre-analytical approach of molecular biology techniques].

J. Sabourin, E. Selva, P. Hofman, 2010, Annales de pathologie.

NGS analysis on tumor tissue and cfDNA for genotype-directed therapy in metastatic NSCLC patients. Between hope and hype?

C. Marquette, S. Leroy, P. Hofman, 2017, Expert review of anticancer therapy.

Immunohistochemistry to identify EGFR mutations or ALK rearrangements in patients with lung adenocarcinoma.

P. Validire, J. Soria, A. Bernheim, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

Salivary detection of COVID-19: clinical performance of oral sponge sampling for SARS-CoV-2 testing

C. Marquette, S. Leroy, J. Benzaquen, 2021, ERJ Open Research.

Clinical performance of oral sponge sampling for detection by RT-PCR of SARS-CoV-2

C. Marquette, S. Leroy, E. Selva, 2021, medRxiv.

Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications.

A. Bozec, J. Santini, P. Vielh, 2010, Current medicinal chemistry.

Overexpression of carbonic anhydrase XII in tissues from resectable non‐small cell lung cancers is a biomarker of good prognosis

J. Pouysségur, N. Mazure, P. Hofman, 2011, International journal of cancer.

Compounds Triggering ER Stress Exert Anti-Melanoma Effects and Overcome BRAF Inhibitor Resistance.

P. Abbe, C. Bertolotto, R. Ballotti, 2016, Cancer cell.

Activation of the P2RX7/IL-18 pathway in immune cells inhibits lung fibrosis

S. Leroy, P. Hofman, V. Hofman, 2022 .

Immunotherapy in Non-Small Cell Lung Cancer: Biological Principles and Future Opportunities.

C. Marquette, S. Leroy, J. Benzaquen, 2018, Current molecular medicine.

“Sentinel” Circulating Tumor Cells Allow Early Diagnosis of Lung Cancer in Patients with Chronic Obstructive Pulmonary Disease

Marius Ilie, Paul Hofman, Bernard Padovani, 2014, PloS one.

Ultrafast Gene Fusion Assessment for Nonsquamous NSCLC

P. Brousset, C. Marquette, J. Mazières, 2022, JTO clinical and research reports.

Reference standards for gene fusion molecular assays on cytological samples: an international validation study

G. Fontanini, B. Weynand, R. Rosell, 2021, Journal of Clinical Pathology.

Detection of circulating tumor cells from lung cancer patients in the era of targeted therapy: promises, drawbacks and pitfalls.

C. Marquette, J. Mazières, G. Milano, 2014, Current molecular medicine.

Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma

Paul Hofman, Emmanuel Chamorey, Olivier Guérin, 2018, Cancers.

Analytical validation of automated multiplex chromogenic immunohistochemistry for diagnostic and predictive purpose in non-small cell lung cancer.

C. Marquette, J. Benzaquen, P. Hofman, 2022, Lung cancer.

Association of combined PD‐L1 expression and tumour‐infiltrating lymphocyte features with survival and treatment outcomes in patients with metastatic melanoma

P. Hofman, V. Hofman, J. Lacour, 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

A new KIT mutation (N505I) in acral melanoma confers constitutive signaling, favors tumorigenic properties, and is sensitive to imatinib.

P. Bahadoran, C. Bertolotto, R. Ballotti, 2014, The Journal of investigative dermatology.

Gene expression profiling in human gastric mucosa infected with Helicobacter pylori

P. Barbry, B. Mari, X. Hébuterne, 2007, Modern Pathology.

[Primary signet ring cell carcinoma of the eccrine sweat gland in the eyelid. Immunohistochemical and ultrastructural study of a case].

P. Gastaud, J. Santini, V. Hofman, 2002, Journal francais d'ophtalmologie.

Targeted Assessment of the EGFR Status as Reflex Testing in Treatment-Naive Non-Squamous Cell Lung Carcinoma Patients: A Single Laboratory Experience (LPCE, Nice, France)

C. Marquette, J. Benzaquen, P. Hofman, 2020, Cancers.

Association of TRF2 expression and myeloid-derived suppressor cells infiltration with clinical outcome of patients with cutaneous melanoma

E. Gilson, P. Hofman, V. Hofman, 2021, Oncoimmunology.

The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential.

A. Bozec, J. Santini, V. Hofman, 2010, Current medicinal chemistry.

[Issues and current limits for immunohistochemical assessment of PD-L1 status in bronchial biopsies].

C. Marquette, J. Soria, P. Hofman, 2016, Bulletin du cancer.

[Histological diagnosis of lung bacterial necrotizing infections: a study of four fulminant cases].

P. Hofman, V. Hofman, S. Lassalle, 2005, Annales de Pathologie.

Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.

C. Marquette, P. Hofman, V. Hofman, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

High levels of carbonic anhydrase IX in tumour tissue and plasma are biomarkers of poor prognostic in patients with non-small cell lung cancer

J. Pouysségur, N. Mazure, P. Hofman, 2010, British Journal of Cancer.

Metformin monotherapy in melanoma: a pilot, open‐label, prospective, and multicentric study indicates no benefit

P. Bahadoran, R. Ballotti, S. Rocchi, 2017, Pigment cell & melanoma research.

Helicobacter pylori Counteracts the Apoptotic Action of Its VacA Toxin by Injecting the CagA Protein into Gastric Epithelial Cells

A. Sciullo, A. Oldani, M. Cormont, 2009, PLoS pathogens.

Expression of MET in circulating tumor cells correlates with expression in tumor tissue from advanced-stage lung cancer patients

C. Marquette, D. Shames, E. Selva, 2017, Oncotarget.

Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?

Marius Ilie, Paul Hofman, Elodie Long, 2014, Annals of translational medicine.

Response of CAIX and CAXII to in vitro re-oxygenation and clinical significance of the combined expression in NSCLC patients.

J. Pouysségur, N. Mazure, P. Brest, 2013, Lung cancer.

Multiomic analysis of malignant pleural mesothelioma identifies molecular axes and specialized tumor profiles driving intertumor heterogeneity

P. Courtiol, C. Maussion, N. Le Stang, 2023, Nature Genetics.

PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome

C. Marquette, E. Brambilla, P. Hofman, 2016, Modern Pathology.

Automated Analysis of Proliferating Cells Spatial Organisation Predicts Prognosis in Lung Neuroendocrine Neoplasms

G. Serio, G. Alí, G. Fontanini, 2021, Cancers.

Morphological analysis of circulating tumour cells in patients undergoing surgery for non‐small cell lung carcinoma using the isolation by size of epithelial tumour cell (ISET) method

T. Molina, J. Jais, C. Marquette, 2012, Cytopathology : official journal of the British Society for Clinical Cytology.

Automated chromogenic multiplexed immunohistochemistry assay for diagnosis and predictive biomarker testing in non-small cell lung cancer.

P. Hofman, V. Hofman, Marame Hamila, 2018, Lung cancer.

ALK-gene rearrangement: a comparative analysis on circulating tumour cells and tumour tissue from patients with lung adenocarcinoma.

C. Marquette, P. Hofman, V. Hofman, 2012 .

Expression of a truncated active form of VDAC1 in lung cancer associates with hypoxic cell survival and correlates with progression to chemotherapy resistance.

V. Shoshan-Barmatz, J. Pouysségur, N. Mazure, 2012, Cancer research.

Detection of EGFR Mutations From Plasma of NSCLC Patients Using an Automatic Cartridge-Based PCR System

C. Marquette, J. Benzaquen, P. Hofman, 2021, Frontiers in Pharmacology.

The significance of co-mutations in EGFR-mutated non-small cell lung cancer: Optimizing the efficacy of targeted therapies?

P. Hofman, V. Hofman, F. Calabrese, 2023, Lung cancer.

Lack of correlation between MET and PD-L1 expression in non-small cell lung cancer revealed by comparative study of matched biopsies and surgical resection samples.

C. Marquette, J. Benzaquen, P. Hofman, 2023, Lung cancer.

Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients.

C. Marquette, S. Leroy, J. Mazières, 2018, Lung cancer.

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study.

C. Marquette, C. Pison, J. Benzaquen, 2020, The Lancet. Respiratory medicine.

[Immunohistochemistry and personalised medicine in lung oncology: advantages and limitations].

P. Hofman, V. Hofman, S. Lassalle, 2014, Bulletin du cancer.

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients.

P. Hofman, V. Hofman, Marame Hamila, 2018, Journal of visualized experiments : JoVE.

E2F1 inhibition mediates cell death of metastatic melanoma

P. Abbe, C. Bertolotto, R. Ballotti, 2018, Cell Death & Disease.

[Setting up a department of molecular pathology in oncology in a pathology laboratory (LPCE, CHU de Nice)].

C. Marquette, L. Castillo, J. Santini, 2013, Annales de pathologie.

Liquid Biopsy and Genomic Assessment for Lung Cancer

P. Hofman, V. Hofman, M. Ilié, 2019, Oncogenomics.

Clinical value of circulating endothelial cells and of soluble CD146 levels in patients undergoing surgery for non-small cell lung cancer

C. Marquette, E. Selva, P. Hofman, 2014, British Journal of Cancer.

A Real-World Experience from a Single Center (LPCE, Nice, France) Highlights the Urgent Need to Abandon Immunohistochemistry for ROS1 Rearrangement Screening of Advanced Non-Squamous Non-Small Cell Lung Cancer

P. Hofman, V. Hofman, E. Long-Mira, 2023, Journal of personalized medicine.

Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients.

C. Marquette, J. Mazières, J. Sabourin, 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Accurate Detection of SARS-CoV-2 by Next-Generation Sequencing in Low Viral Load Specimens

C. Marquette, S. Leroy, J. Benzaquen, 2023, International journal of molecular sciences.

[Role of the surgical pathologist for tissue management in oncology].

P. Hofman, V. Hofman, S. Lassalle, 2013, Bulletin du Cancer.

Lung injury shifts pulmonary capillary endothelial cells towards regeneration-associated Lrg1+ subpopulations with delayed dynamics in aged mice

A. Günther, C. Marquette, S. Leroy, 2023, bioRxiv.

Abstract 2220: PD-L1 expression in primary tumor and circulating tumor cells in patients with small cell lung carcinomas

C. Marquette, E. Selva, P. Hofman, 2016 .

A Single Dose of COVID-19 mRNA Vaccine Induces Airway Immunity in COVID-19 Convalescent Patients

C. Czerkinsky, S. Leroy, J. Benzaquen, 2021, medRxiv.

Detection of PD-L 1 in circulating tumor cells and white blood cells from patients with advanced non-small cell lung cancer

C. Marquette, S. Leroy, E. Selva, 2017 .